  Hyperglycaemia in Pregnancy ( HIP) is a global issue as it increases risks for both the mother and child. There remains considerable disparity in clinical practice and national policies for HIP screening. FIGO , EBCOG and EAPM have joined forces to address this disparity in clinical care and reduce the burden of inter-generational Non-Communicable disease.